+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Comprehensive analysis of short peptides in sera from patients with IgA nephropathy

Comprehensive analysis of short peptides in sera from patients with IgA nephropathy

Rapid Communications in Mass Spectrometry 23(23): 3720-3728

We analyzed serum short peptides comprehensively to know whether they were useful to characterize IgA nephropathy (IgAN). Serum samples from 26 patients with untreated IgAN and 25 healthy donors were tested. Short peptides with molecular weights of approximately 7 kDa, purified from the serum samples by magnetic-beads-based weak cation exchange, were detected by mass spectrometry. Then the peptide peaks detected were subjected to the multivariate data analysis by SIMCA-P+ containing principal component analysis (PCA) and orthogonal partial-least-squares-discriminate analysis (OPLS-DA). A total of 92 peptide peaks were detected in the tested serum samples. The OPLS-DA analysis revealed that the profile of all the peptide peak intensities discriminated the IgAN group and the healthy group completely with a high R2 value (0.919) and a high Q2 value (0.861). Further, the profile of only five peptide peaks was found to discriminate the two groups. By tandem mass spectrometry and database searching, three of the five peptides which increased in the IgAN group were identified as fragments of fibrinogen alpha chain, and the two peptides which increased in the healthy group were identified as fragments of complement C3f and kininogen-1 light chain. Taken together, the profile of the serum short peptides would be useful to discriminate IgAN and healthy conditions. Further, the five peptides may be candidate serum markers for IgAN and may be related to pathogenesis of IgA.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 052269874

Download citation: RISBibTeXText

PMID: 19902551

DOI: 10.1002/rcm.4315

Related references

Comprehensive investigation of disease-specific short peptides in sera from patients with systemic sclerosis: complement C3f-des-arginine, detected predominantly in systemic sclerosis sera, enhances proliferation of vascular endothelial cells. Arthritis and Rheumatism 56(6): 2018-2030, 2007

Matrix production in cultured human mesangial cells is induced by IgC and sera sera from patients with IgA nephropathy. Journal of the American Society of Nephrology 7(9): 1772, 1996

Circulating factors in sera or peripheral blood mononuclear cells in patients with membranous nephropathy or diabetic nephropathy. Journal of Korean Medical Science 12(6): 539-544, 1997

Fine-mapping naturally occurring NY-ESO-1 antibody epitopes in melanoma patients' sera using short overlapping peptides and full-length recombinant protein. Molecular Immunology 54(3-4): 465-471, 2013

Analysis of IgG immune complexes in sera from patients with membranous nephropathy: role of IgG4 subclass and low-avidity antibodies. Nephron 57(2): 131-136, 1991

Comprehensive regression analysis of hepatitis B virus X antigen level and anti-HBx antibody titer in the sera of patients with HBV infection. Pathology Oncology Research 12(1): 34-40, 2006

Maldi-TOF analysis of portal sera of pancreatic cancer patients: identification of diabetogenic and antidiabetogenic peptides. Clinica Chimica Acta; International Journal of Clinical Chemistry 343(1-2): 119-127, 2004

Antibodies to synthetic peptides from Epstein-Barr nuclear antigen-1 in sera of patients with early rheumatoid arthritis and in preillness sera. Journal of Rheumatology 17(11): 1442-1449, 1990

High-sensitivity HLA class I peptidome analysis enables a precise definition of peptide motifs and the identification of peptides from cell lines and patients' sera. Proteomics 16(10): 1570-1580, 2016

Antinuclear autoantibodies in sera of patients with IgA nephropathy. Nephron 55(1): 33-36, 1990

Specificity of IgA antibodies in sera from patients with IgA nephropathy. Nihon Jinzo Gakkai Shi 34(4): 353-360, 1992

Analysis of cytokines in seminal plasma and blood sera of patients with chronic prostatitis during immunotherapy with natural complex of cytokines and antimicrobial peptides. Zhurnal Mikrobiologii, Epidemiologii, i Immunobiologii: 57-61, 2007

Comprehensive microbiome analysis of tonsillar crypts in IgA nephropathy. Nephrology Dialysis Transplantation 32(12): 2072-2079, 2017

Levels of interleukin 18 in the sera and urine of patients with IgA nephropathy. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 728A, 2001

Cold-reacting antinuclear factor in sera from patients with IgA nephropathy. Journal of Laboratory and Clinical Medicine 94(1): 76-87, 1979